Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |